Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Dec 1;158(6):1912-23.
doi: 10.1084/jem.158.6.1912.

Acceptor-suppressor T cell hybridoma with a receptor recognizing antigen-specific suppressor factor

Acceptor-suppressor T cell hybridoma with a receptor recognizing antigen-specific suppressor factor

I Takei et al. J Exp Med. .

Abstract

An acceptor hybridoma with a receptor that recognizes the keyhole limpet hemocyanin (KLH)-specific suppressor T cell factor (KLH-TsF) was established after the fusion of C57BL/6 splenic T cells enriched with KLH-coated petri dishes. The cloned hybridoma (34S-281) could be specifically activated by stimulation with the conventional KLH-TsF or monoclonal KLH-TsF from three different hybridomas in the absence of the relevant antigen (KLH) and it started to produce another factor that suppresses the antibody response against DNP-KLH in a KLH-specific fashion. The KLH specificity of the TsF was required for activation. The new factor was found not to bind the KLH but to be absorbed with the KLH-TsF-producing hybridoma. It is thus strongly suggested that the acceptor site has a complementary structure (antiidiotype) for the KLH-TsF. Moreover, the idiotypic determinant on KLH-TsF was found to have a structure similar to that on some of the anti-KLH antibodies, since the acceptor hybridoma was specifically killed by the conventional anti-KLH antibodies and complement. Drawing on the above results, the idiotype-antiidiotype network in the conventional antigen system is discussed.

PubMed Disclaimer

References

    1. Immunol Rev. 1977;34:119-38 - PubMed
    1. J Exp Med. 1977 Oct 1;146(4):970-85 - PubMed
    1. Immunol Rev. 1978;39:108-36 - PubMed
    1. Nature. 1979 Apr 5;278(5704):555-8 - PubMed
    1. J Exp Med. 1983 May 1;157(5):1379-95 - PubMed